EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT.
about
Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori infection: a review of current diagnosis and managementInfectious Aetiology of Marginal Zone Lymphoma and Role of Anti-Infective TherapyClinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphomas: A reviewConcurrent gastric and pulmonary mucosa-associated lymphoid tissue lymphomas with pre-existing intrinsic chronic inflammation: a case report and a review of the literatureDe-escalating therapy in gastric aggressive lymphomaRituximab plus bendamustine is active in pretreated patients with extragastric marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma)Increased risk of gastric adenocarcinoma after treatment of primary gastric diffuse large B-cell lymphoma.Rituximab plus subcutaneous cladribine in patients with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a phase II study by the Arbeitsgemeinschaft Medikamentose Tumortherapie.Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: a distinct entity with lower aggressiveness and higher chemosensitivityClinical features, treatment and outcome of mucosa-associated lymphoid tissue (MALT) lymphoma of the ocular adnexa: single center experience of 60 patients.Approach to Helicobacter pylori infection in geriatric population.Limited role of bone marrow aspiration and biopsy in the initial staging work-up of gastric mucosa-associated lymphoid tissue lymphoma in Korea.Study of regulatory T-cells in patients with gastric malt lymphoma: influence on treatment response and outcome.Helicobacter pylori research: historical insights and future directions.Running in the family: MALT lymphoma and autoimmune disease in mother and daughter.Subcutaneous dissemination pattern in extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue lymphoma.Delayed Efficacy After Treatment With Lenalidomide or Thalidomide in Patients With Mucosa-Associated Lymphoid Tissue Lymphoma.Evaluation of the clinical characteristics, management, and prognosis of 103 patients with gastric mucosa-associated lymphoid tissue lymphomaClinical Outcome of Eradication Therapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma according to H. pylori Infection Status.Helicobacter Pylori "Test-and-Treat" Strategy for Management of Dyspepsia: A Comprehensive ReviewComparative outcomes of oncologic therapy in gastric extranodal marginal zone (MALT) lymphoma: analysis of the SEER-Medicare databaseChronicles of a cancer foretold: 35 years of gastric cancer risk assessmentA phase II study of lenalidomide in patients with extranodal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT lymphoma).Prevalence of clarithromycin-resistant Helicobacter pylori strains in gastric mucosa-associated lymphoid tissue lymphoma patients.Management of Suspicious Mucosa-Associated Lymphoid Tissue Lymphoma in Gastric Biopsy Specimens Obtained during Screening Endoscopy.Gastric malt lymphoma: Analysis of a series of consecutive patients over 20 years.Detection of the Helicobacter pylori CagA protein in gastric mucosa-associated lymphoid tissue lymphoma cells: clinical and biological significanceBowel perforation in intestinal lymphoma: incidence and clinical features.Helicobacter pylori Eradication Therapy Is Effective as the Initial Treatment for Patients with H. pylori-Negative and Disseminated Gastric Mucosa-Associated Lymphoid Tissue LymphomaRadiation therapy for gastric mucosa-associated lymphoid tissue lymphoma: dose-volumetric analysis and its clinical implications.Role of Helicobacter pylori in gastric mucosa-associated lymphoid tissue lymphomasCorrelation of Endoscopic Findings of Gastric Mucosa-Associated Lymphoid Tissue Lymphoma with Recurrence after Complete Remission.The Role of Endoscopic Ultrasound in the Diagnosis and Management of Primary Gastric Lymphoma.Recent developments in nongastric mucosa-associated lymphoid tissue lymphoma.Review article: common misconceptions in the management of Helicobacter pylori-associated gastric MALT-lymphoma.Extranodal and splenic small B-cell lymphoma.Gastrointestinal lymphoma: recent advances in diagnosis and treatment.3rd Brazilian Consensus on Helicobacter pylori.Inflammation, immunity, vaccines for Helicobacter pylori infection.
P2860
Q26741090-68AB5F5E-292E-47AC-A11A-173784477417Q26770344-37BB1631-8BC5-4C12-BB42-6DBBAD0789C6Q26771654-A1A0CED3-BB47-4879-9343-D3830E1429A0Q26799731-7E638CDE-3399-4FCD-9A53-5D656E32D788Q27026867-1F727D5B-23E2-4A0A-A978-0CA3296C44ADQ27694672-6B6774BC-701A-459D-BB6F-F04C0A12D833Q28296146-073C4FB8-385E-404E-B934-47D2AD30A2E7Q31142314-2AC6AD9E-F4C8-4608-B257-03C919A9AA13Q33403350-F190D26A-221F-42B7-B843-D91F5E300453Q33840213-71920F5F-191C-425E-A728-DA050EBCB5A5Q33982223-5C495E4C-E3FD-4B50-9A4B-1E9698DDB1E8Q34047658-BF68064D-6CA3-4CE1-BC4D-8EFDC31B4DD3Q34432169-15BC581B-AF28-45BA-B81E-A5F47A8B9248Q34532146-13937C1B-6C4D-4772-BCD5-3969CB229B2DQ34764772-C6B933D1-1C91-48B0-9993-C2DAFBC56DAAQ35812536-431E7AF7-87F2-47CB-84FC-4923B065A0C7Q35930647-E2F6E01F-A522-4B29-98C4-ABC4E8FBEF62Q36452240-7403A7B1-489B-4975-A1E0-7B526A304ED9Q36640612-B55C8355-40A6-4F0A-BCD2-F0FD3F0FE0D9Q36681114-1E126615-789A-407C-AEA6-CB938F6BDCC8Q36740047-F58C5B14-DCD3-49E3-B31F-0CD4BBE7A6EDQ36777008-4DF5D866-3A7E-426E-9109-BF9F02DA8A1EQ36859578-43D27EAB-585E-4F49-8330-1EAD81A02345Q36862393-A277B5DA-684F-478D-A091-3306EEB4294AQ36958048-3E5725BF-9B09-4D16-A5EA-AEA448C52EA7Q36989781-ED44D7CA-BDD4-4280-B6EA-D8596B8791CFQ37045745-8AA52B89-EC85-43D7-80E0-4BCEA31A4491Q37061428-A366A7AB-12F4-4016-B107-7D38BBBCEE0BQ37126916-489265BA-867B-4001-819C-A6FCFEA01CA8Q37213503-E9864AD5-6179-4AEC-9938-BD2C4CE4DF0DQ37343455-5681A448-4931-477E-902D-B6DD6DC8CC9BQ37578581-8CDFEC5D-7452-4E53-9079-01D91F40F07AQ37633931-2E294241-D2EC-4CC2-8C77-B1538C04B7CFQ37733616-0A3BE7D5-1D93-4975-8507-96D9CBFBE922Q37910013-FD926B22-7072-4C78-8A1E-3A2814FBC961Q37932613-5C6F75E9-014A-432A-85C9-369B7668BAACQ38071075-0CBE049E-48A6-4FAD-B9A9-A5EA58B9AF73Q38103339-68F5A3B7-7A2B-4DD0-A857-892F56E5CB8AQ38113105-ED888874-6B0B-44EB-986E-709CB24D01B4Q38134867-4169F539-5002-43A7-B95C-8F823EDCA49A
P2860
EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT.
@en
EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT.
@nl
type
label
EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT.
@en
EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT.
@nl
prefLabel
EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT.
@en
EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT.
@nl
P2093
P356
P1433
P1476
EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT.
@en
P2093
A Ruskoné-Fourmestraux
A Wotherspoon
B M P Aleman
C Montalban
EGILS group
P304
P356
10.1136/GUT.2010.224949
P407
P577
2011-02-11T00:00:00Z